5.0
Nov 14, 2024
Recommend
CEO approval
Business Outlook
Pros
The company has grown enormously organically and inorganically. It has a great leadership team that understands the pharmaceutical commercial landscape. Offshore development centers are starting to gain momentum in terms of technical innovation.
Cons
There is still some technical debt from recent acquisitions.